Protecting Patients from Bad Drugs: A Risk-Based Approach to Medicines Quality Surveillance (parts 1&2)
Poor-quality medicines can cause treatment failure and adverse reactions, increase morbidity and mortality, and contribute to the development of drug resistance. They also waste resources that could otherwise be used to benefit public health. These videos explain how designing and implementing programs that monitor medicines quality through a risk-based approach allows countries to tailor activities according to local needs, optimize limited resources, and focus efforts on areas that present the greatest risks to public health.
The Case for Quality: Incentivizing Investments in Access to Quality Medicines
In this discussion at the 2018 World Health Assembly, global health thought leaders discuss the need to encourage investments in strengthening medicines regulatory systems. Panel members address incentives to investments and the key interventions they should empower: collaborative solutions to improving access to quality-assured medicines, local capacity building, knowledge sharing, and global coordination.